...
首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Midterm results of endovascular treatment of complicated acute type B aortic dissection.
【24h】

Midterm results of endovascular treatment of complicated acute type B aortic dissection.

机译:复杂的急性B型主动脉夹层血管内治疗的中期结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: The operative mortality and morbidity of patients with complicated acute type B aortic dissection remain high. The endovascular approach has been proposed as a potential alternative. The purpose of this study is to review the contemporary outcome of patients undergoing endovascular treatment for complicated acute type B aortic dissection. METHODS: A retrospective analysis of 28 patients undergoing endovascular interventions for acute type B aortic dissection was performed. Kaplan-Meier survival analysis was used for statistical computation. RESULTS: Indications for emergency endografting were rupture in 4 (14%) patients, severe lower body malperfusion in 8 (29%) patients, visceral/renal malperfusion in 7 (25%) patients, persistent chest pain despite proper anti-impulsive therapy in 5 (18%) patients, uncontrollable hypertension in 1 (4%) patient, and acute dilatation of false lumen with impending rupture in 3 (11%) patients. Three (11%) patients died early. Three patients died during follow-up of non-aorta-related causes. Overall survival was 82% and 78% at 1 and 5 years' follow-up, respectively. The aorta-related mortality was 10% for the entire follow-up period. Complete thrombosis of the false lumen in the thoracic aorta was achieved in 22 (85%) members of the surviving cohort, and partial thrombosis was achieved in the remainder. The rate of treatment failure according to Stanford criteria was 18% at 5 years. Mean follow-up was 36 months, and follow-up was complete in 28 (100%) patients. CONCLUSIONS: Thoracic aortic endografting for complicated acute type B aortic dissection can be performed with a relatively low postoperative morbidity and mortality in experienced hands. The endovascular approach to life-threatening complications of acute type B aortic dissection appears to have a favorable outcome in midterm follow-up.
机译:目的:并发急性B型主动脉夹层的患者的手术死亡率和发病率仍然很高。已经提出了血管内方法作为潜在的替代方法。这项研究的目的是回顾接受血管内治疗的复杂急性B型主动脉夹层患者的当代疗效。方法:对28例接受急性B型主动脉夹层血管内介入治疗的患者进行回顾性分析。 Kaplan-Meier生存分析用于统计计算。结果:紧急内移植的适应症有4例(14%)破裂,8例(29%)严重下体灌注不良,7例(25%)内脏/肾灌注不良,尽管在患者中进行了适当的抗冲动治疗仍持续胸痛5例(18%),1例(4%)的患者无法控制的高血压以及3例(11%)的假性管腔急性扩张伴即将破裂。三名(11%)患者提前死亡。三例患者在非主动脉相关原因的随访期间死亡。随访1年和5年,总生存率分别为82%和78%。在整个随访期间,与主动脉相关的死亡率为10%。幸存的队列中有22名成员(85%)实现了胸主动脉假腔的完全血栓形成,其余部分实现了部分血栓形成。根据斯坦福标准,治疗失败率在5年时为18%。平均随访时间为36个月,对28例(100%)患者进行了随访。结论:胸膜主动脉内移植治疗复杂的急性B型主动脉夹层可以在经验丰富的手中以较低的术后发病率和死亡率进行手术。在中期随访中,采用血管内方法治疗威胁生命的急性B型主动脉夹层并发症似乎具有良好的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号